85 related articles for article (PubMed ID: 34300326)
1. Comprehensive mapping of saliva by multiomics in children with idiopathic nephrotic syndrome.
Ye Q; Liu H; Meng H; Wang D; Zhang J; Zhu S; Mao J
Nephrology (Carlton); 2024 Apr; ():. PubMed ID: 38637907
[TBL] [Abstract][Full Text] [Related]
2. Steroid-Resistant Nephrotic Syndrome due to
Kachmar J; Boyer O; Lipska-Ziętkiewicz B; Morinière V; Gribouval O; Heidet L; Balasz-Chmielewska I; Benetti E; Cloarec S; Csaicsich D; Decramer S; Gellermann J; Guigonis V; Hogan J; Bayazit AK; Melk A; Nigmatullina N; Oh J; Ozaltin F; Ranchin B; Tsimaratos M; Trautmann A; Antignac C; Schaefer F; Dorval G;
Kidney Int Rep; 2024 Apr; 9(4):973-981. PubMed ID: 38765578
[TBL] [Abstract][Full Text] [Related]
3. Podocyte-targeted therapies - progress and future directions.
Meliambro K; He JC; Campbell KN
Nat Rev Nephrol; 2024 May; ():. PubMed ID: 38724717
[TBL] [Abstract][Full Text] [Related]
4. Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis.
Salfi G; Casiraghi F; Remuzzi G
Front Immunol; 2023; 14():1247606. PubMed ID: 37795085
[TBL] [Abstract][Full Text] [Related]
5. Potential Urine Proteomic Biomarkers for Focal Segmental Glomerulosclerosis and Minimal Change Disease.
Chebotareva NV; Vinogradov A; Brzhozovskiy AG; Kashirina DN; Indeykina MI; Bugrova AE; Lebedeva M; Moiseev S; Nikolaev EN; Kononikhin AS
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293475
[TBL] [Abstract][Full Text] [Related]
6. New Insights into Hemopexin-Binding to Hemin and Hemoglobin.
Lechuga GC; Napoleão-Pêgo P; Morel CM; Provance DW; De-Simone SG
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409149
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms of Proteinuria in Minimal Change Disease.
Purohit S; Piani F; Ordoñez FA; de Lucas-Collantes C; Bauer C; Cara-Fuentes G
Front Med (Lausanne); 2021; 8():761600. PubMed ID: 35004732
[TBL] [Abstract][Full Text] [Related]
8. The management of idiopathic nephrotic syndrome in children.
Hodson E
Paediatr Drugs; 2003; 5(5):335-49. PubMed ID: 12716220
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Hemopexin in the Pathogenesis of Proteinuria in Children with Idiopathic Nephrotic Syndrome.
Pukajło-Marczyk A; Zwolińska D
J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300326
[TBL] [Abstract][Full Text] [Related]
11. The Role of TNF-α in the Pathogenesis of Idiopathic Nephrotic Syndrome and Its Usefulness as a Marker of the Disease Course.
Pukajło-Marczyk A; Zwolińska D
J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610653
[No Abstract] [Full Text] [Related]
12. Podocyte sphingomyelin phosphodiesterase acid-like 3b decreases among children with idiopathic nephrotic syndrome.
Watanabe S; Hirono K; Aizawa T; Tsugawa K; Joh K; Imaizumi T; Tanaka H
Clin Exp Nephrol; 2021 Jan; 25(1):44-51. PubMed ID: 32946006
[TBL] [Abstract][Full Text] [Related]
13. [Interleukin-17 concentration in serum and urine of children with idiopathic nephrotic syndrome].
Kiliś-Pstrusińska K; Zwolińska D; Medyńska A; Wawro A; Kordecki H
Przegl Lek; 2006; 63 Suppl 3():198-200. PubMed ID: 16898529
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
